Joyhep Tablet contains Ursodeoxycholic Acid 300mg, a hydrophilic bile acid used primarily for the treatment of various hepatobiliary disorders. Ursodeoxycholic Acid acts by reducing the cholesterol content of bile, thereby decreasing the formation of cholesterol gallstones and promoting their dissolution. It also exhibits cytoprotective properties by stabilizing hepatocyte membranes and improving bile flow, which helps in the management of cholestatic liver diseases such as primary biliary cholangitis and intrahepatic cholestasis. Joyhep Tablet is indicated for patients with non-calcified cholesterol gallstones who are not suitable candidates for surgery, as well as for those with chronic liver conditions characterized by impaired bile secretion. The medication is typically administered orally, with dosage and duration tailored according to the patient's clinical condition and response to therapy. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort, though it is generally well tolerated. Caution is advised in patients with biliary obstruction or acute inflammation of the gallbladder. Regular monitoring of liver function tests is recommended during treatment to assess efficacy and detect potential adverse effects. Joyhep Tablet should be used under medical supervision to ensure safe and effective management of hepatobiliary disorders.